View in EDS HTML Full Text PDF Full Text

Surufatinib plus paclitaxel as second-line therapy for advanced gastric cancer: a single-arm, phase 2 clinical trial.

Saved in:
Bibliographic Details
Title: Surufatinib plus paclitaxel as second-line therapy for advanced gastric cancer: a single-arm, phase 2 clinical trial.
Authors: Han, Ting1 (AUTHOR), Zhuo, Meng1 (AUTHOR), Zheng, Xinyi2 (AUTHOR), Wu, Xiuqi1 (AUTHOR), Jiao, Feng1 (AUTHOR), Cui, Jiujie1 (AUTHOR), Wang, Tao3 (AUTHOR), Qiu, Xiaoxia1 (AUTHOR), Su, Yingjie4 (AUTHOR), Lin, Xiaolin1 (AUTHOR) renjilxl@163.com, Xiao, Xiuying1 (AUTHOR) xiaoxiuying2002@163.com
Source: Cellular Oncology (2211-3428). Dec2025, Vol. 48 Issue 6, p2073-2084. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:22113428
DOI:10.1007/s13402-025-01127-9